NCT06991725

Brief Summary

A cross-sectional design study will be carried out to explore the morphological muscle properties and alterations in muscle composition on a macroscopic level in children with spastic cerebral palsy (CP). Muscle composition will be assessed using quantitative Magnetic Resonance Imaging (qMRI) and shear wave elastography (SWE), while macroscopic muscle size properties will be evaluated through 'Three-dimensional freehand ultrasound (3DfUS).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for all trials

Timeline
32mo left

Started Feb 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress33%
Feb 2025Dec 2028

Study Start

First participant enrolled

February 3, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 16, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 28, 2025

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

April 29, 2026

Status Verified

May 1, 2025

Enrollment Period

3.8 years

First QC Date

May 16, 2025

Last Update Submit

April 28, 2026

Conditions

Keywords

Spastic Cerebral PalsyMuscle composition3D freehand ultrasoundShear wave elastographyMuscle morphologyRange of motionStiffnessSpasticity

Outcome Measures

Primary Outcomes (9)

  • Evaluation of the muscle volume of the medial gastrocnemius muscle

    Estimation of the muscle belly volume by 3DfUS. Muscle volume will be normalized to anthropometric growth.

    Cross-sectional data collection at day 1.

  • Evaluation of the muscle length of the medial gastrocnemius muscle

    Estimation of the muscle belly length, tendon length and muscle tendon unit complex length by 3DfUS. Muscle lengths will be normalized to anthropometric growth

    Cross-sectional data collection at day 1.

  • Evaluation of the muscle echo-intensity of the medial gastrocnemius muscle

    Estimation of the echo-intensity by 3DfUS.

    Cross-sectional data collection at day 1.

  • Evaluation of the fat fraction of the medial gastrocnemius muscle.

    Estimation of the fat fraction by Dixon sequence (MRI): a comparison of muscle fat fraction between children with CP and healthy age-matched TD controls in different age groups.

    Cross-sectional data collection at day 1.

  • Indirect evaluation of collagen content of the medial gastrocnemius muscle

    Indirect estimation of collagen content by T1ƿ relaxation time (MRI): a comparison between children with CP and healthy age-matched TD controls in different age groups.

    Cross-sectional data collection at day 1.

  • Evaluation of passive muscle stiffness across the medial gastrocnemius muscle.

    Estimation of the passive muscle stiffness by shear modulus (SWE): a comparison of passive muscle stiffness between children with CP and healthy age-matched TD controls in different age groups.

    Cross-sectional data collection at day 1.

  • Evaluation of differences in fat fraction in different regions across the medial gastrocnemius muscle.

    Comparison of differences in fat fraction across three regions (proximal, midbelly, distal) of the muscle belly in children with CP compared to TD children.

    Cross-sectional data collection at day 1.

  • Evaluation of differences in passive muscle stiffness in different regions across the medial gastrocnemius muscle.

    Comparison of differences in passive muscle stiffness across three regions (midbelly, distal, upper fascia of midbelly) of the muscle belly in children with CP compared to TD children.

    Cross-sectional data collection at day 1.

  • Evaluation of the muscle strength (ankle torque).

    Evaluating the muscle strength (ankle torque) using the handheld dynamometer.

    Cross-sectional data collection at day 1.

Study Arms (2)

Children with spastic cerebral palsy

Children between 2 years and 16 years old

Typically developing children

Children between 2 years and 16 years old

Eligibility Criteria

Age2 Years - 16 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children with spastic cerebral palsy, who have routine follow-up care at the CP reference center of the University Hospitals Leuven. Typically developing children are recruited through the social (family and friends) and professional (colleagues) network of involved researchers and thesis students, who approach participants through flyers, social media.

You may qualify if:

  • Children (boys/girls) with congenital brain lesion, confirmed with neuro-imaging such as MRI
  • At high-risk for CP or diagnosed spastic type of CP
  • (Suspected) Gross Motor Function Classification Scale (GMFCS) Level I-III
  • Uni or bilateral involvement
  • Aged between 2-16 years

You may not qualify if:

  • Presence of dyskinesia or ataxia
  • Severe co-morbidities (cognitive problems)
  • BTX treatment in the gastrocnemius in the past 10 months
  • Previous surgery at the investigated muscles.
  • Previous orthopedic or neurosurgery
  • Severe ankle deformities
  • Weight for height values \>2SD or \<-2SD from mean
  • Typically developing children
  • Aged between 2-16 years
  • History of neurological, orthopedic or muscular problems
  • Involvement in an elite or high-performance sporting program (Children performing the same sports for \> 5 hours/week will be excluded)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UZ Leuven

Leuven, Vlaams-Brabant, 3000, Belgium

RECRUITING

MeSH Terms

Conditions

Cerebral PalsyMuscle Spasticity

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Kaat Desloovere, Prof.dr.

    Department of Rehabilitation Sciences, KU Leuven, Belgium

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. dr.

Study Record Dates

First Submitted

May 16, 2025

First Posted

May 28, 2025

Study Start

February 3, 2025

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

April 29, 2026

Record last verified: 2025-05

Locations